You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

List of Excipients in API VANDETANIB

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing VANDETANIB

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Genzyme Corporation	CAPRELSA	vandetanib	58468-7820	CELLULOSE, MICROCRYSTALLINE	2028-08-08
Genzyme Corporation	CAPRELSA	vandetanib	58468-7820	CROSPOVIDONE	2028-08-08
Genzyme Corporation	CAPRELSA	vandetanib	58468-7820	DIBASIC CALCIUM PHOSPHATE DIHYDRATE	2028-08-08
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for VANDETANIB

Excipient focus: CELLULOSE, MICROCRYSTALLINE

VANDETANIB drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Genzyme Corporation	vandetanib	58468-7820
>Company	>Ingredient	>NDC

VANDETANIB drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSPOVIDONE

VANDETANIB drug variants containing CROSPOVIDONE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Genzyme Corporation	vandetanib	58468-7820
>Company	>Ingredient	>NDC

VANDETANIB drug variants not containing CROSPOVIDONE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

VANDETANIB drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Genzyme Corporation	vandetanib	58468-7820
>Company	>Ingredient	>NDC

VANDETANIB drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

VANDETANIB drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Genzyme Corporation	vandetanib	58468-7820
>Company	>Ingredient	>NDC

VANDETANIB drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

VANDETANIB drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Genzyme Corporation	vandetanib	58468-7820
>Company	>Ingredient	>NDC

VANDETANIB drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL 300

VANDETANIB drug variants containing POLYETHYLENE GLYCOL 300

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Genzyme Corporation	vandetanib	58468-7820
>Company	>Ingredient	>NDC

VANDETANIB drug variants not containing POLYETHYLENE GLYCOL 300

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POVIDONE

VANDETANIB drug variants containing POVIDONE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Genzyme Corporation	vandetanib	58468-7820
>Company	>Ingredient	>NDC

VANDETANIB drug variants not containing POVIDONE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

VANDETANIB drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Genzyme Corporation	vandetanib	58468-7820
>Company	>Ingredient	>NDC

VANDETANIB drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.